Human Reproduction, Vol 12, 1720-1722, Copyright © 1997 by Oxford University Press
BJ Roozenburg, HJ van Dessel, JL Evers and RS Bots
Patients suffering from normogonadotrophic anovulation and infertility are
initially treated with clomiphene citrate. Those who do not respond to
clomiphene citrate usually receive gonadotrophin treatment which is
labour-intensive, expensive, and associated with an increased risk of
multiple pregnancies and ovarian hyperstimulation syndrome. We treated 22
patients with clomiphene resistant normogonadotrophic anovulation with
naltrexone (an opioid receptor blocker) alone or naltrexone in combination
with an antioestrogen. In 19 patients ovulation and resumption of a regular
menstrual cycle was achieved and in 12 out of 19 a singleton pregnancy was
observed. In conclusion, ovulation can be induced successfully using
naltrexone alone or naltrexone in combination with an anti-oestrogen in
clomiphene citrate resistant anovulatory patients. Compared to
gonadotrophin induction of ovulation, this method is safe, simple and
inexpensive.
ARTICLES
Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment
Department of Obstetrics and Gynaecology, St Elisabeth Hospital, Tilburg, The Netherlands.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
